Is There an Association Between Maternal Pap Test Use and Adolescent Human Papillomavirus Vaccination?

doi:10.1016/j.jadohealth.2012.05.015

Journal of Adolescent Health

Volume 52, Issue 2, February 2013, Pages 212-218

https://doi.org/10.1016/j.jadohealth.2012.05.015 Get rights and content

Abstract

Purpose

To identify the association between mother's recent receipt of a Pap test and daughter's uptake and completion of the three-shot human papillomavirus (HPV) vaccination series.

Methods

We used cross-sectional data from the 2008 to 2010 Behavioral Risk Factor Surveillance System from 9 U.S. states and Puerto Rico and logistic regression models to examine the association between mother's receipt of a Pap test in the past 3 years and daughter's uptake and completion of the three-shot HPV vaccination series among adolescent girls aged 9–17 years (N = 4,776).

Results

Approximately one-quarter of adolescent girls began the HPV vaccination series, and 13.6% completed the three-shot series. Uptake and completion were more likely among girls whose mothers had obtained a Pap test within the past 3 years—for HPV uptake, odds ratio: 1.342, 95% confidence interval: 1.073–1.692; for HPV completion, odds ratio: 1.904; 95% confidence interval: 1.372–2.721—but the relationship between mother's recent Pap test and vaccine uptake was explained by the mother's use of a personal doctor and obtaining a routine physical examination in the past year.

Conclusions

HPV vaccination uptake and completion were more likely among adolescent girls whose mothers obtained a recent Pap test. Interventions designed to educate mothers on the importance of HPV vaccination and to facilitate relationships between physicians and mothers may prove successful at increasing HPV vaccination among adolescent girls.

Section snippets

Sample

This cross-sectional study used data from the 2008, 2009, and 2010 Behavioral Risk Factor Surveillance System (BRFSS) [31]. The BRFSS is the world's largest monthly telephone health survey, tracking adult health behaviors, health care use, and health outcomes from all 50 U.S. states, the District of Columbia, and U.S. territories since 1984. In 2008, questions about HPV vaccination for people aged ≤17 years were included as optional modules for states. One child from each sampled household was

Results

Descriptive statistics for the sample are presented in Table 2. Approximately one-quarter (26.6%) of the sample of 4,776 adolescent girls aged 9–17 years ever started the HPV vaccine, and only 13.6% completed the three-shot series. The overwhelming majority of mothers (90%) have received a Pap test in the past 3 years. It is important to note that because a large proportion of our sample came from Texas, our study sample overrepresents Hispanics. In addition, blacks are underrepresented in our

Discussion

Because parental consent is generally required to provide the HPV vaccine to adolescents, mothers play an essential role in facilitating vaccine uptake among their daughters. Further, because mothers shoulder the majority of responsibility for children's involvement in the health care system [23], [24], girls' completion of the three-shot series is highly contingent on mothers' desire, motivation, and ability to get their daughters to the necessary follow-up visits. Our finding that 27% of

Acknowledgments

The authors thank the U.S. Centers for Disease Control and Prevention for the Behavioral Risk Factor Surveillance System data. S.F.W. receives research funding from the National Cancer Institute, K01CA155417-01A1. Everyone who has contributed to this study has been acknowledged herein. The authors do not have any potential, perceived, or real conflicts of interest. The National Cancer Institute had no role in any part of the study. The first author wrote the first draft of the manuscript. No

References (39)

R.M. Haupt et al.
The efficacy and safety of the quadrivalent human papillomavirus 6/11/16/18 vaccine Gardasil
J Adolesc Health
(2011)
P.M. Webb et al.
HIV immunization: Acceptability and anticipated effects on sexual behavior among adolescents
J Adolesc Health
(1999)
R.L. Cook et al.
Factors associated with completion of human papillomavirus vaccine series among young women in enrolled in Medicaid
J Adolesc Health
(2010)
L.M. Niccolai et al.
Racial/Ethnic and poverty disparities in human papillomavirus vaccination completion
Am J Prev Med
(2011)
A.L. McRee et al.
Vaccinating adolescent girls against human papillomavirus—Who decides?
Prev Med
(2010)
R.M. Mays et al.
Parental perspectives on vaccinating children against sexually transmitted infections
Soc Sci Med
(2004)
G.D. Zimet et al.
Predictors of STI vaccine acceptability among parents and their adolescent children
J Adolesc Health
(2005)
B.M. Slomovitz et al.
Are women ready for the HPV vaccine?
Gynecol Oncol
(2006)
J.A. Kahn et al.
Impact of maternal communication about skin, cervical, and lung cancer prevention on adolescent prevention behaviors
J Adolesc Health
(2011)
A. Vargas Bustamante et al.
Use of preventive care services among Latino subgroups
Am J Prev Med
(2010)

S.S. Coughlin et al.

Breast and cervical cancer screening practices among Hispanic women in the United States and Puerto Rico, 1998–1999

Prev Med

(2002)

R. Caskey et al.

Knowledge and early adoption of the HPV vaccine among girls and young women: Results of a national survey

J Adolesc Health

(2009)

S.L. Rosenthal et al.

Uptake of HPV vaccine: Demographics, sexual history and values, parenting style, and vaccine attitudes

J Adolesc Health

(2008)

S.L. Pruitt et al.

Geographic disparity, area poverty, and human papillomavirus vaccination

Am J Prev Med

(2010)

A.B. Bernstein

Motherhood, health status, and health care

Womens Health Issues

(2001)

Cervical cancer statistics

(2011)

F.X. Bosch et al.

.Chapter 1: Human papillomavirus and cervical cancer—Burden and assessment of causality

J Natl Cancer Inst Monogr

(2003)

E.F. Dunne et al.

Prevalence of HPV infection among females in the United States

JAMA

(2007)

L.E. Markowitz et al.

Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

MMWR Recomm Rep

(2007)

Cited by (20)

Adolescents’ Patterns of Well-Care Use Over Time: Who Stays Connected
2021, American Journal of Preventive Medicine
Well-care use can positively impact adolescents’ current and future health. Understanding adolescents’ longitudinal well-care use is critical to determine to whom and when to target engagement strategies to improve healthcare access. This study describes prospective well-care use patterns from childhood through adolescence stratified by sex.
The sample (N=6,872) was drawn from the Child/Young Adult component of the household-based 1979 National Longitudinal Survey of Youth consisting of biological children born to female respondents (1980–1997). Well-care use (routine checkup with a doctor within last year) data were assessed from age 5 years (1986–2003) until age 17 years (1998–2015). Conducted in 2019, latent class analyses stratified by sex identified well-care use patterns reported over 7 biennial time points adjusted for cohort, race/ethnicity, urbanicity, maternal education, and insurance.
A total of 4 well-care use classes emerged for female adolescents: the majority belonged to Engaged (37%) and Moderately Engaged (39%) classes and the remainder belonged to Gradually Re-engaged (14%) and Disengaged-with-Rebound (10%) classes. A total of 3 classes emerged for male adolescents: the majority belonged to the Persistently Disengaged (48%) class and the remainder belonged to Engaged (34%) and Gradually Re-engaged (18%) classes. For both sexes, comparing each cohort with the first, Engaged class membership increased for subsequent cohorts. Less engaged well-care use classes had more non-Hispanic White adolescents living in rural areas with lower insurance coverage. Maternal education differentiated well-care use classes for male but not for female adolescents, being higher for male adolescents in the Engaged class than in other classes.
These findings highlight that well-care use patterns for both sexes changed during the transition from childhood to adolescence and that class membership differed by covariates. These results suggest that sex-specific strategies may be needed to enhance adolescents’ well-care use engagement over time.
Emergence of oncogenic high-risk human papillomavirus types and cervical cancer
2019, Emerging and Reemerging Viral Pathogens: Volume 1: Fundamental and Basic Virology Aspects of Human, Animal and Plant Pathogens
Human papillomavirus (HPV) is a deoxyribonucleic acid (DNA) virus belonging to Papillomaviridae, which genome is about 8000 base pairs. Over the last 20 years, more than 200 types of this virus have been identified, which induce specific cancers.
HPV is the first cause of sexually transmitted genital infections, and the most common in the world because of its ease of transmission. While the virus can spread through a simple direct skin contact, HPV infection usually doesn’t develop clinical symptoms or diseases in the majority of subjects.
Thus the persistence of a genital infection generated by some types of high-risk oncogenic HPV in cervical cells induces precancerous cervical lesions, susceptible to cause cancer after 15 to 20 years in women with a normal immune system.
Notably, it seems that various genera of HPV have appeared including HPV16, HPV18, HPV31, HPV33, HPV35, HPV39, HPV52, HPV56, HPV58, and HPV67. These HPVs have been associated to approximately 75% of the cervical cancer cases. While several studies have demonstrated the involvement of two types of virus (HPV16 and HPV18) in 82% of the cervical cancer cases as causative agents, and specifically host–virus interactions controlled through viral oncoproteins E6 and E7. Thus after the transfection of the oncogenic HPV viral DNA, E6 and E7 express and inactivate the tumor suppressor proteins p53 and retinoblastoma, thus inhibiting apoptosis, which increases the proliferation of epithelial cells and consequently the risk of tumorigenesis.
Sociodemographic predictors are associated with compliance to a vaccination-reminder in 9692 girls age 14, Denmark 2014–2015
2018, Preventive Medicine Reports
We aimed to identify sociodemographic predictors of compliance after receiving a personalised reminder on lacking vaccinations against MMR (Measles, Mumps, Rubella) and/or HPV (Human Papilloma Virus) among parents of Danish adolescent girls.
A nationwide register-based study, including all 14-year-old girls (15 May 2014–14 May 2015) lacking either MMR, HPV-vaccination or both. Vaccination-compliance following a postal reminder was modelled using multivariable logistic regression and included the following socio-demographic predictors: maternal age, education, employment and ethnicity. Birth order, number of siblings, family-structure, location of residence, and household income.
The parents of 9692 girls received a reminder. Out of 4940 exclusively lacking an HPV-vaccine, 15.3% were subsequently vaccinated. Among 2026 only lacking an MMR vaccination, 8.5% were vaccinated. Among 2726 girls lacking both, 5% received an HPV, 4.4% an MMR and 5.4% received both vaccinations. We identified sociodemographic differences between reminderletter-compliers and non-compliers, also according to vaccination types. Non-western descendants were more likely to receive HPV-vaccination, although the association was only significant for those who only lacked HPV (OR 2.02, 95% 1.57–2.59). For girls only lacking an MMR, regional differences were identified. Among girls lacking both vaccines, girls of mothers with intermediate (OR 0.63, 0.42–0.95) or basic education (OR 0.43, 0.24–0.75) were less likely to be vaccinated compared to girls of higher educated mothers.
Reminders were in particular effective in increasing HPV uptake among immigrants of non-Western ethnicity. We found reminders to be less effective among less educated mothers whose daughters lacked both vaccines. To increase the coverage in this group, additional interventions are needed.
Socioeconomic inequalities to accessing vaccination against human papillomavirus in France: Results of the Health, Health Care and Insurance Survey, 2012
2017, Revue d'Epidemiologie et de Sante Publique
In France, human papillomavirus (HPV) vaccination coverage among adolescents and young women is low and decreasing. We analysed data from the 2012 Health, Health Care and Insurance Survey with the aim of identifying factors associated with this vaccination. We also compared the socioeconomic profile of unvaccinated young women to that of women who do not undergo cervical cancer screening (CCS).
Data were collected through interviews and self-administered questionnaires completed by a randomised sample of Health insurance beneficiaries. Two analyses were performed using Poisson regression: one to investigate the determinants of CCS uptake in women aged 25–65 years old (n = 4508), the other to investigate the determinants of HPV vaccination in young women aged 16–24 years old (n = 899). A sub-analysis was performed in 685 “daughter–mother” couples from the same household in order to analyse the association between participation to CCS in mothers and HPV vaccination in daughters.
Factors significantly associated both to a lower CCS uptake and to an insufficient HPV vaccination were the lack of a complementary private health insurance (P = 0.023 and P = 0.037, respectively) and living in a family with a low household income (P < 0.001 and P = 0.005, respectively). A low education level was associated to a lower CCS uptake (P < 0.001). The absence of CCS uptake in the last three years in mothers was associated to a lower level of HPV vaccination in their daughter (P = 0.014).
Women who do not undergo CCS and HPV unvaccinated young women tend to be of modest socioeconomic status. Unvaccinated young females tend to have mothers who do not undergo CCS and are therefore at risk of benefiting from none of the two cervical cancer preventive measures. The current implementation strategy concerning HPV vaccination in France may therefore increase inequalities regarding cervical cancer prevention.
En France, les couvertures vaccinales (CV) du vaccin contre les papillomavirus humains (HPV) des adolescentes et des jeunes femmes sont insuffisantes et en régression. Nous avons analysé les données de l’Enquête santé et protection sociale de 2012 afin d’explorer les facteurs associés à cette vaccination. Nous avons également comparé le profil socioéconomique des jeunes femmes non vaccinées à celui des femmes participant au dépistage du cancer du col par frottis cervico-utérin (FCU).
Les informations ont été recueillies par interview et auto-questionnaire sur un échantillon aléatoire représentatif des bénéficiaires de l’Assurance maladie. Deux analyses ont été effectuées par régression de Poisson : l’une pour investiguer les facteurs associés au dépistage du cancer du col chez les femmes de 25–65 ans (n = 4508), l’autre pour investiguer les facteurs associés à la vaccination HPV chez les jeunes filles de 16–24 ans (n = 899). Une sous-analyse a été effectuée chez 685 couples « filles–mères » d’un même ménage afin d’étudier la relation entre réalisation du FCU chez la mère et vaccination HPV chez la fille.
Les facteurs significativement associés à la fois à une moindre participation au dépistage par FCU et à une moindre vaccination HPV étaient le fait de ne pas disposer d’une couverture complémentaire maladie privée (p = 0,023, p = 0,037, respectivement) et de vivre dans une famille à revenus faibles (p < 0,001 ; p = 0,005, respectivement). Un bas niveau d’éducation était associé à un moindre dépistage par FCU (p < 0,001). L’absence de dépistage de la mère par FCU dans les trois dernières années était associée à une moindre vaccination HPV chez la fille (p = 0,014).
Les femmes qui ne participent pas au dépistage par FCU et les jeunes femmes non vaccinées contre le HPV appartiennent plutôt aux catégories sociales les plus modestes. Les jeunes filles non vaccinées ont tendance à avoir des mères qui ne participent pas au dépistage par FCU et risquent donc de ne bénéficier d’aucune des deux mesures de prévention du cancer du col. Les modalités actuelles de mise en œuvre de la vaccination HPV en France risquent ainsi de creuser les inégalités vis-à-vis de la prévention du cancer du col.
Effective Dual Method Contraceptive Use and HPV Vaccination Among U.S. Adolescent and Young Adult Females
2014, Women's Health Issues
Problem Behavior Theory posits that risky behaviors cluster in individuals, implying that protective behaviors may follow a similar pattern. The purpose of this study was to determine whether the protective behavior of effective dual method contraception use at first and most recent sexual intercourse is associated with HPV vaccination among adolescent and young adult females.
National Survey of Family Growth (2006–2010) data were used to examine the association between women's contraception use during first and most recent sexual intercourse and HPV vaccination. Women aged 15 to 24 years (n = 1,820) served as the study sample.
At first and last sexual intercourse, effective dual method contraception use was reported by 15.3% and 16.8% women, respectively; 27.8% reported receiving at least one dose of the human papillomavirus (HPV) vaccine. Higher HPV vaccination rates were observed among dual method users at first and last sexual intercourse (36.4% and 48.2%, respectively). This trend was also observed across age groups (15–19 year olds vs. 20–24 year olds). In adjusted models, among all respondents, dual users at last sexual intercourse were significantly more likely to be vaccinated, whereas at first sexual intercourse only younger dual users were more likely to report HPV vaccination.
Findings suggest that the protective behavior of dual method contraceptive use at first and most recent sexual intercourse may serve as a predictor of another complementary health behavior, HPV vaccination, particularly among adolescent females. More research is needed to understand behavioral clustering to design related multi-focused women's health interventions.
Association between maternal preventive care utilization and adolescent vaccination: It's not just about pap testing
2014, Journal of Pediatric and Adolescent Gynecology
Citation Excerpt :
In addition, parental attitudes and behaviors, especially maternal, may play a significant role in the decision to vaccinate. Several studies observed associations between women's healthcare utilization related to sexual health, such as Papaniculou (Pap) and STI testing, and acceptability of HPV vaccination.13–16 However, studies have found mixed results when investigating the association between HPV vaccine acceptability and mothers' experiences with HPV-related diseases and other STIs, with the majority showing no statistically significant association.13,14,17–21
To examine the association between maternal preventive care utilization and human papillomavirus (HPV) vaccine uptake by their adolescent daughters.
A cross-sectional study using immunization records from administrative claims and the state health department's immunization information system from June 2006 through May 2011.
Commercially-insured Michigan females aged 13-17 in May 2011 and their mothers. Mothers were identified using relationship information on the insurance contract.
Using logistic regression, we investigated whether initiating and/or completing the HPV vaccine series were associated with maternal preventive care utilization (Papaniculou testing, mammograms, primary care office visits) independently and using a combined maternal preventive care utilization index.
Among 38,604 mother-daughter pairs, 36% of daughters initiated and 22% completed the HPV vaccine series. Maternal utilization of each recommended service was modestly associated with both daughter's initiation and completion of the HPV vaccine. Effect estimates for receipt of Papaniculou test on vaccine initiation (OR = 1.07, 95% CI = 1.06-1.08) were not any higher than for mammograms (OR = 1.10, 95% CI = 1.08-1.11) or primary care office visits (OR = 1.07, 95% CI = 1.06-1.09). Using a maternal preventive care utilization index, vaccine uptake increased with an increasing number of received services.
Maternal receipt of recommended preventive care, which may reflect general attitudes toward prevention, is as or more predictive of daughter's vaccination status than cervical cancer screening alone. Engaging women in broad routine preventive care practices may have additional positive effects on adolescent HPV vaccination beyond those achieved through cervical cancer prevention efforts alone.

View all citing articles on Scopus

View full text

Original articleIs There an Association Between Maternal Pap Test Use and Adolescent Human Papillomavirus Vaccination?

Abstract

Purpose

Methods

Results

Conclusions

Section snippets

Sample

Results

Discussion

Acknowledgments

J Adolesc Health

J Adolesc Health

J Adolesc Health

Am J Prev Med

Prev Med

Soc Sci Med

J Adolesc Health

Gynecol Oncol

J Adolesc Health

Am J Prev Med

Prev Med

J Adolesc Health

J Adolesc Health

Am J Prev Med

Womens Health Issues

Cervical cancer statistics

.Chapter 1: Human papillomavirus and cervical cancer—Burden and assessment of causality

J Natl Cancer Inst Monogr

Prevalence of HPV infection among females in the United States

JAMA

Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

MMWR Recomm Rep

Original article
Is There an Association Between Maternal Pap Test Use and Adolescent Human Papillomavirus Vaccination?